Submitted by Anonymous (not verified) on 28 November 2025 - 8:06
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 29, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 29, Status: Authorised